Skip to main content

Table 1 IGF2BP2 expression and clinicopathological characteristics of patients with colorectal cancer

From: IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism

Characteristics

IGF2BP2 low experssion

IGF2BP2 high experssion

P

 

N

%

N

%

  

Gender

      

 Male

9

18.0

13

26.0

0.2545

 

 Female

16

32.0

12

24.0

 

Age(years)

      

 < 56

11

22.0

13

26.0

0.5661

 

 > 56

14

28.0

12

24.0

 

Tumor size

      

 T1 or T2

10

20.0

2

4.0

0.0081*

 

 T3 or T4

15

30.0

23

46.0

 

Lymph node

      

 N0

22

44.0

13

26.0

0.0176*

 

 N1

3

6.0

10

20.0

 

 N2

0

0

2

4.0

 

Grade

      

 1

3

6.0

3

6.0

0.2822

 

 2

11

22.0

19

38.0

 

 2–3

4

8.0

1

2.0

 

 3

3

6.0

2

4.0

 

Stage

      

 I

10

20.0

0

0

0.0008*

 

 II

11

22.0

13

26.0

 

 III-IV

4

8.0

12

24.0

 
  1. * indicates P < 0.05